The United States Drug Abuse Testing Market is projected to grow significantly, reaching US$ 3.71 billion by 2033, up from ...
“It is disturbing to see increased use of fentanyl on the job and in combination with other drugs, given fentanyl’s extreme potency, which can increase risk of impairment, accidents, and potential ...
Quest Diagnostics has introduced a new pharmacogenomic (PGx) laboratory testing service designed to assist healthcare providers in understanding their patients' genetic responses to specific ...
SECAUCUS, N.J., Sept. 2, 2025 /PRNewswire/ -- The percentage of employees in the general U.S. workforce testing positive for fentanyl in random drug tests far exceeded those in pre-employment testing, ...
15d
Fentanyl use on the rise in workplace drug tests nationwide but on the decline in NYS, report finds
The positivity rate for urine tests indicating the presence of the deadly synthetic opioid was 0.55% in 2024, increasing almost 15% from 0.48% one year earlier, according to an analysis of more than 8 ...
AUSTIN (KXAN) — A new report from Quest Diagnostics, a diagnostic testing and health information services provider, revealed the percentage of employed people who test positive for fentanyl in random ...
The percentage of employees in the general U.S. workforce who had tested positive for fentanyl in random drug tests was far ...
SECAUCUS, N.J. - Quest Diagnostics (NYSE:DGX), a $20.2 billion healthcare diagnostics leader currently trading near its 52-week high at $179.88, announced Thursday the launch of a new pharmacogenomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback